Search results
Results from the WOW.Com Content Network
If a woman had “co-testing” (a combination of an HPV test and a Pap test) and her Pap smear results were normal but she had a positive HPV test, her doctor might advise her to come back in a ...
Co-testing with a Pap test and HPV test is recommended because it decreases the rate of false-negatives. According to the National Cancer Institute, "The most common test detects DNA from several high-risk HPV types, but it cannot identify the types that are present. Another test is specific for DNA from HPV types 16 and 18, the two types that ...
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
The two screening methods available are the Pap smear and testing for HPV. CIN is usually discovered by a screening test, the Pap smear. The purpose of this test is to detect potentially precancerous changes through random sampling of the transformation zone. Pap smear results may be reported using the Bethesda system (see above).
In the absence of such lesions, beginning at age 30 and lasting through age 64, the screening interval may be lengthened to every five years and an HPV test may be substituted for the Pap smear.
Medicare Part B covers the costs of HPV testing. It provides coverage once every 5 years for people between the ages of 30 and 65 years without HPV symptoms.The HPV test is part of the Pap test ...
However, it is acceptable to screen this age group with a Pap smear alone every 3 years or with an FDA-approved primary high risk HPV test every 5 years. [11] In women over the age of 65, screening for cervical cancer may be discontinued in the absence of abnormal screening results within the prior 10 years and no history of high-grade lesions ...
One of the first tests that allows patients to self-collect samples to screen for human papillomavirus (HPV) will soon be available in doctors' offices. In May, the U.S. Food and Drug ...